May 14, 2026 Nurix Therapeutics Presents New Preclinical and Phase 1 Translational Data Supporting Bexobrutideg (NX-5948) in Chronic Spontaneous Urticaria at the 2026 Society for Investigative Dermatology Annual Meeting
May 14, 2026 nCino Announces Timing of its First Quarter Fiscal Year 2027 Financial Results Conference Call